GIMER Medical’s pain relief system StimOn is cleared to market by US FDA

(Taipei, Taiwan; Aug. 27, 2022) GIMER Medical’s pain relief system StimOn is cleared to market by US FDA on Aug. 26, 2022.

 

StimOn Pain Relief System is a handheld stimulator designed to pass electrical signals via surface electrodes through the skin to the underlying nerves. It may be used as a TENS device to aid the blocking of pain signals traveling to the brain.

 

The 510(K) clearance of StimOn can be found on US FDA’s website: https://www.fda.gov/medical-devices/510k-clearances/august-2022-510k-clearances

Share: